Saturday, September 24, 2022
This conference has already taken place.
Radiologists and technologists will jointly attend the sessions which will focus on important areas of shared responsibility and will promote a dialogue between registrants and faculty regarding problems encountered in the practice setting.
ASRT has approved this conference for 9.25 Category A Credits.
This is a Virtual conference only, using Zoom. You will be sent an email to the email address you state on your registration.
For pricing information, see pricing tab below.
Dates and Times
Start: 9/24/2022 7:00 AM
End: 9/24/2022 5:00 PM
- Utilize imaging criteria (morphology) in determining benign vs. malignant potential of a lymph node.
- Recognize the various approaches to management of the axilla in breast cancer patients.
- Describe advantages and disadvantages of surgical excision for borderline breast lesions.
- Perform radiology-pathologic correlations following the biopsy of borderline breast lesions.
- Discuss the clinical aspects of the common breast symptoms.
- Apply imaging modalities to diagnose or exclude breast cancer in patients who present with breast symptoms.
- Define the criteria of triple negative breast cancer.
- Incorporate imaging criteria to detect and diagnose triple negative breast cancer.
- Utilize the revised BIRADS recommended for ultrasound breast screening.
- Relate underlying statistical assumptions that support ultrasound breast screening.
- Recognize the effects of tomosynthesis on the imaging evaluation of asymmetries.
- Apply imaging algorithm in evaluating asymmetries detected at mammography and tomosynthesis.
- Apply MRI to evaluate equivocal imaging findings.
- Utilize MRI to manage clinical symptoms of the breast.
- Recognize the various implant types and reconstruction techniques.
- Differentiate implant complications vs artifacts.
- Explain the physics behind rapid breast MRI acquisition.
- Recognize the potential; utility of breast MRI for large scale population screening.
- Define the clinical indications of neoadjuvant therapy.
- Utilize imaging to assess for response in breast cancer patients being treated with neoadjuvant therapy.
- Implement clinically relevant decision-making in difficult cases, as presented in an interactive, real-time audience participation session.
- Appropriately use the ACR Lexicon with difficult breast imaging cases.
|Residents, Radiologic Technologists and Other Healthcare Professionals||$200.00|
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.